Adiponectin
ADPN
Description
"Adiponectin" test evaluates levels of adiponectin, a hormone produced by fat cells that influences blood sugar control and fat metabolism. Low levels are associated with insulin resistance, obesity, and cardiovascular risk. Doctors often recommend it when assessing metabolic imbalance, early insulin resistance, or unexplained weight gain. Abnormal results help identify early metabolic dysfunction. Based on findings, care plans may include lifestyle changes or treatment for insulin sensitivity. Regular monitoring supports long-term metabolic health and personalized diabetes risk management.
Test Category
Hormones
Procedure
Invasive
Sample Type
Blood – Serum
Units
Micrograms Per Milliliter
Procedure Category
Blood Draw
Test Group
Complete Blood Sugar Group, Complete Metabolic Group
Test Group Description
Complete Blood Sugar Group: This expanded group includes a more comprehensive set of tests, offering a thorough evaluation of diverse facets of blood sugar levels for a more detailed understanding of metabolic health. Complete Metabolic Group: A comprehensive suite of tests designed to evaluate metabolic function, offering detailed insights into various aspects of metabolism and associated health conditions.
Optimal Range
For All Individuals:
Conventional Unit: 18.00–37.00 µg/mL
SI Unit: 18.00–37.00 mg/L
Normal Range
For All Individuals:
Conventional Unit: 4.50–37.00 µg/mL
SI Unit: 4.50–37.00 mg/L
Results That Differ From The Norm (Direct and Indirect Causes)
Decreased levels may indicate:
Atherosclerosis (buildup of plaque in arteries)
Benign prostatic hypertrophy (enlargement of the prostate gland)
Metabolic syndrome (cluster of conditions including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels)
Obesity (excessive body fat accumulation)
Type 2 diabetes (metabolic disorder characterized by insulin resistance)
Key Reasons For Testing
Metabolic Health Assessment: Evaluates fat tissue function to detect issues like insulin resistance and metabolic syndrome.
Diabetes Risk Prediction: Identifies lower adiponectin levels linked to a higher risk of type 2 diabetes.
Cardiovascular Risk Assessment: Detects lower levels associated with increased risk of heart disease.
Liver Function Evaluation: Helps identify conditions like fatty liver disease.
Response to Lifestyle Interventions: Monitors improvements in metabolism after diet and exercise changes.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Lau DC, Dhillon B, Yan H, et al. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031-H2041.
[2] Diez JJ, Iglesias P. The role of the novel adipocyte-derived protein adiponectin in human disease. Eur J Endocrinol.2003;148(3):293-300.
[3] Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288-1295.
[4] Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin, and vascular inflammatory disease. Trends Cardiovasc Med. 2003;13(4):170-175.
[5] Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595-1599.
[6] Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet.2003;361(9353):226-228.
[7] Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291(14):1730-1737.
[8] Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab. 2008;93(8):3165-3172.
[9] Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439-451.
[10] Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol.2004;24(1):29-33.
[11] Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996;120(4):803-812.